https://www.selleckchem.com/pr....oducts/vevorisertib-
Furthermore, XF-hiPSC-ECs functionally responded to shear stress with typical cell alignment and gene expression. Finally, we successfully endothelialized decellularized human vessels with XF-hiPSC-ECs in a dynamic bioreactor system. In conclusion, we developed xenogeneic-free conditions for generating functional hiPSC-ECs suitable for vascular tissue engineering, which will further move TEVG therapy toward clinical application. Clinical assessment of bone health by Dual-Energy X-ray Absorptiometry (DXA) in the pae
Like
Comment
Share
